The October issue of our monthly People Pathways newsletter is now available to read here!
Cambridge, UK, October 12, 2023 – Mestag Therapeutics (“Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions to develop impactful treatments for patients, today announced the appointment of expert advisors Dr. Cassandra Choe-Juliak MD, formerly Chief Medical Officer at Flame Biosciences; Dr. Greg Elson, an expert in end-to-end development of novel antibody-based products with more than 30 years of industry experience; and Samantha Vieira MBA PMP, formerly Chief Operating Officer at Anjarium Biosciences.
AMSBIO has published a case study that describes how a team of scientists, led by Dr. Roger Kamm from the Massachusetts Institute of Technology (MIT), has developed a protocol for the fabrication of a 3D microfluidic neuromuscular platform that can be used to model Motor Neuron Diseases (MND’s).
Material manufacturer Xampla has appointed a new chief executive to scale-up the business.
Alexandra French, an experienced chemist with a degree in natural sciences from the University of Cambridge, has joined Xampla to lead it through the next phase of growth.
Press release
Macomics Announces the Appointment of Kevin Lee as Independent Non-Executive Director
Edinburgh and Cambridge, UK, 19 October 2023 - Macomics Ltd, a leader in macrophage drug discovery, announces that it has appointed Kevin Lee Ph.D., MBA as Independent Non-Executive Director.
Pioneering partnership to drive development of new tests and treatments to tackle deadly antimicrobial resistance, which could otherwise kill 10 million a year by 2050
Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30 million initiative supporting early-stage innovation against antimicrobial resistance (AMR) to save lives. PACE has today (19 October 2023) announced its first funding call with up to £10 million available to support innovators developing new antimicrobials.
The next UCL SysMIC online course in coding, modelling & data analysis, will start on Monday 6th November 2023.
Participants will become confident in using the Python, R and MATLAB platforms, developing interdisciplinary skills that will make them more effective researchers with the confidence to develop and apply computational techniques in modelling and data analysis to their own work.
The new ABLE 3D Magnetic Stir and Disposable Bioreactor System from AMSBIO provides cost-effective, lab-scale production of induced pluripotent stem (iPS) cell spheroid culture.
Are you a scientist or clinician working in the wonderful world of cell and gene therapy and drug development? If yes, this is the podcast for you!
During this episode of 'Conversations in Drug Development' you can learn more about the 'Recent Trends in Oncology Drug Development'.
Aimed at in-house lawyers who are not already experts in a given technology but would like to know more, each of these three sessions will give an overview of the science as well as jargon-busting tips, followed by some legal considerations and hot topics.
To find out more and register, click here - https://www.bristows.com/viewpoint/events/